EP4125903
AÐFERÐIR FYRIR UPPHAFSSKÖMMTUN ARÍPÍPRASÓLAR Í MEÐFERÐUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
1.4.2021EP published:
9.10.2024EP application number:
21720012.0
EP translation filed:
15.11.2024Grant published:
15.12.2024EPO information:
European Patent Register
Max expiry date:
31.3.2041Expiry date:
31.3.2026Next due date:
30.4.2026
Title in English:
METHODS FOR DOSE INITIATION OF ARIPIPRAZOLE TREATMENTSLanguage of the patent:
English
Timeline
Today
1.4.2021EP application
9.10.2024EP Publication
15.11.2024Translation submitted
15.12.2024Registration published
31.3.2026Expires
Owner
Name:
Otsuka Pharmaceutical Co., Ltd.Address:
2-9, Kanda Tsukasa-machi Chiyoda-ku, Tokyo 101-8535, JP
Inventor
Name:
HARLIN, MatthewAddress:
Osaka-shi, Osaka 540-0021, JP
Name:
WANG, XiaofengAddress:
Osaka-shi, Osaka 540-0021, JP
Name:
WANG, YanlinAddress:
Osaka-shi, Osaka 540-0021, JP
Name:
RAOUFINIA, ArashAddress:
Osaka-shi, Osaka 540-0021, JP
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
202063003544 PDate:
1.4.2020Country:
US
Classification
Categories:
A61K 31/496, A61P 25/18
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 21.2.2025
Expires: 31.3.2026
Payer: G.H. Sigurgeirsson ehf.